The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Side by side

Compound comparison

Check interactions →Open as saved/share list

Khavinson Bioregulators

Bioregulator · Grade C

Goals
cognition, longevity, immune, hormonal
Evidence
0 RCT / 5 animal / 4 in vitro
Routes
injectable-sc, injectable-im, oral
WADA
No
FDA
Not approved
Cancer caution
caution
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Khavinson Bioregulator Cluster

Bioregulator · Grade C

Goals
cognition, longevity, immune
Evidence
—
Routes
injectable-sc, injectable-im, nasal
WADA
No
FDA
Not approved
Cancer caution
caution
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Epitalon

Bioregulator · Grade C

Goals
cognition, sleep, longevity
Evidence
0 RCT / 5 animal / 3 in vitro
Routes
injectable-sc, nasal
WADA
No
FDA
Not approved
Cancer caution
hard-stop
Typical dose
—
Half-life
—
Primary mechanism
Mechanism diagram showing the compound's primary signaling pathway and downstream effects.
View full report →

Pinealon

Bioregulator · Grade C

Goals
cognition, sleep, longevity
Evidence
0 RCT / 1 animal / 2 in vitro
Routes
injectable-sc, injectable-im
WADA
No
FDA
Not approved
Cancer caution
caution
Typical dose
Community protocols commonly cite 2 mg daily for 10 days; evidence is extrapolated
Half-life
Unknown in humans; short peptide, likely rapid systemic clearance
Primary mechanism
Direct chromatin-interaction hypothesis
View full report →